Non-influence of lipid lowering therapy in atrial fibrillation recurrence. 

 -  2013 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0167-5273 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Atrial Fibrillation/dt [Drug Therapy]<br/>*Hydroxymethylglutaryl-CoA Reductase Inhibitors/tu [Therapeutic Use]<br/>Atrial Fibrillation/us [Ultrasonography]<br/>Echocardiography<br/>Humans<br/>Recurrence<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Rate<br/>Treatment Outcome
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Washington Hospital Center
<br/><br/><label>Index Terms--Occupation: </label><br/>Medicine/General Internal Medicine
<br/><br/><label>Index Terms--Function: </label><br/>Letter<br/>Randomized Controlled Trial